Novartis Plan To Save $1.6 Billion By 2010 Includes Cutting Another 2,500 Jobs
This article was originally published in The Pink Sheet Daily
Executive Summary
Two-year plan aims to spark upswing in pharma growth by 2H 2008 after loss of brand sales and regulatory setbacks in 2007, CEO Vasella says.
You may also be interested in...
Novartis First Quarter Sales Bolstered By Gleevec, Diovan
Pharmaceutical revenues are up 6 percent, hampered by a 19 percent drop in U.S. pharma sales.
Novartis First Quarter Sales Bolstered By Gleevec, Diovan
Pharmaceutical revenues are up 6 percent, hampered by a 19 percent drop in U.S. pharma sales.
Novartis Appoints Specialty Drug Division Head To Lead North American Pharma Unit
Ludwig Hantson becomes head of the North American pharma business and CEO of Novartis Pharmaceuticals immediately, replacing Alex Gorsky.